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Prenatal alcohol exposure may cause a number of health complications for the mother and developing
fetus, including Fetal Alcohol Spectrum Disorders (FASD). This study aimed to estimate the pooled
prevalence of i) alcohol use (any amount) and binge drinking (4 or more standard drinks on a single
occasion) during pregnancy, and ii) Fetal Alcohol Syndrome (FAS) and FASD among the general and
Aboriginal populations in Canada and the United States, based on the available literature. Comprehensive
systematic literature searches and meta-analyses, assuming a random-effects model, were conducted. It
was revealed that about 10% and 15% of pregnant women in the general population consume alcohol in
Canada and the United States, respectively, and that about 3% of women engage in binge drinking during
pregnancy in both countries. However, the prevalence of alcohol use during pregnancy in the Aboriginal
populations of the United States and Canada were found to be approximately 3e4 times higher,
respectively, compared to the general population. Even more alarmingly, it was estimated that
approximately one in ﬁve women in the Aboriginal populations in both countries engage in binge
drinking during pregnancy. Further, among the general population of Canada, the pooled prevalence was
estimated to be about 1 per 1000 for FAS and 5 per 1000 for FASD. However, compared to the general
population, the prevalence of FAS and FASD among the Aboriginal population in Canada was estimated to
be 38 times and 16 times higher, respectively. With respect to the United States, the pooled prevalence of
FAS and FASD was estimated to be about 2 per 1000 and 15 per 1,000, respectively, among the general
population, and 4 per 1000 and 10 per 1,000, respectively, among the Aboriginal population. The FAS and
FASD pooled prevalence estimates presented here should be used with caution due to the limited
number of existing studies and their methodological limitations. Based on the results of the current
study, it is evident that there is an urgent need for implementing more effective national prevention and
surveillance strategies to monitor and lower the prevalence of alcohol consumption during pregnancy
and FASD.
© 2016 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
In North America, alcohol consumption during pregnancy andh Policy Research, Centre for
to, ON, Canada, M5S 2S1.
.
Masson SAS. This is an open acceas a result, Fetal Alcohol Spectrum Disorders (FASD) is well recog-
nized as an important public health concern and the leading known
cause of mental deﬁciency among North Americans. However,
despite public health efforts to increase awareness of the risks
associated with drinking during pregnancy, a signiﬁcant proportion
of pregnancies in North America are alcohol-exposed. Alcohol is a
teratogen that can readily cross the placenta resulting in irrevers-
ible damage to the brain and other organs of the developingss article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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pregnancy place their child(ren) at risk of developing FASD, and can
experience a number of other adverse pregnancy outcomes
including stillbirth (Kesmodel et al., 2002), spontaneous abortion
(Henriksen et al., 2004), premature birth (Albertsen et al., 2004;
Kesmodel et al., 2000), intrauterine growth retardation (Yang
et al., 2001), and low birth weight (O'Callaghan et al., 2003). FASD
is an umbrella term, which includes Fetal Alcohol Syndrome (FAS),
Partial FAS (pFAS), Alcohol-Related Neurodevelopmental Disorder
(ARND), and Alcohol-Related Birth Defects (ARBD; depending on
the classiﬁcation system/diagnostic guidelines; see, for example,
Chudley et al., (2005) and Stratton et al., (1996)). Very recently, it
has been suggested that the term FASD be used as a diagnostic
term, rather than just an umbrella term (Cook et al., 2016).
The manifestations of FASD include a broad array of congenital
anomalies and growth impairments, along with cognitive, behav-
ioural, emotional, and adaptive functioning deﬁcits, all of which can
have lifelong implications. Later in life, these deﬁcits may lead to
secondary disabilities, including academic failure, substance abuse,
mental health problems, contact with law enforcement, and an
inability to live independently and obtain/maintain employment
(Streissguth et al., 1996). When combined with the primary dis-
abilities, these secondary disabilities increase the complexity of
care the person requires and result in signiﬁcant social and eco-
nomic costs to society. In a recently conducted study in Canada, the
cost associated with FASD totaled approximately $1.8 billion (from
about $1.3 as the lower estimate up to $2.3 billion as the upper
estimate) in 2013 (Popova et al., 2016a).
Determining the prevalence at which alcohol consumption
during pregnancy and FASD occur is the ﬁrst step towards truly
understanding their scope and severity. Prevalence estimates are
not only vital for informing policymakers of the impact of these
conditions, but they are also integral to raising awareness of alcohol
use during pregnancy and its potential consequences e that is,
FASD. Therefore, the objectives of the current study were to esti-
mate the pooled prevalence of i) alcohol use (any amount) and
binge drinking (4 or more standard drinks on a single occasion)
during pregnancy, and ii) FAS and FASD among the general and
Aboriginal populations in Canada and the United States.
2. Materials and Methods
The main approaches taken were two independent compre-
hensive systematic literature searches and meta-analyses for each
country, which were conducted and reported according to the
standards set out in Preferred Reporting Items for Systematic Re-
views and Meta-Analyses (Liberati et al., 2009).
2.1. Prevalence of Alcohol Use and Binge Drinking During Pregnancy
Among the General and Aboriginal Populations in Canada and the
United States
2.1.1. Comprehensive systematic literature search strategy
A comprehensive systematic literature search was performed to
identify all studies that have reported the prevalence of alcohol use
and/or binge drinking during pregnancy among the general and/or
Aboriginal populations in Canada or the United States. The search
was conducted in multiple electronic bibliographic databases,
including (in alphabetical order): Canadian Centre on Substance
Abuse Library Collection Database, Campbell Collaboration,
CINAHL, Cochrane Database of Systematic Reviews, CSA Sociologi-
cal Abstracts, Embase, ERIC, Google Scholar, Medline, National
Institute on Alcohol Abuse and Alcoholism's Alcohol and Alcohol
Problems Science Database, PsycINFO, Scopus, Social Work Ab-
stracts, andWeb of Science (including Science Citation Index, SocialSciences Citation Index, Arts and Humanities Citation Index). The
search was conducted using the following key words: 1) alcohol,
binge, OR ethanol; AND 2) behavi*, consum*, OR drink*; AND 3)
maternal, mother, primigravida, OR wom*n; AND 4) pregnant,
pregnanc*, OR prenatal; AND 5) epidemiology, frequenc*, occur-
rence, OR prevalence; AND 6) Canada, North America*, United
States*, OR USA. The search was performed to identify studies
published between January 1984 and June 2014 (i.e., in the last 30
years), without language restriction. Further, the content pages of
the major epidemiological journals, as well as citations in the
relevant articles were manually screened.2.1.2. Inclusion and exclusion criteria
The following inclusion criteriawere applied to determine study
eligibility: i) consisted of original quantitative research published in
a peer-reviewed journal or scholarly report; and ii) reported the
prevalence of alcohol consumption and/or binge drinking during
pregnancy in Canada or the United States. Articles were excluded if
they i) did not include abstainers in their samples, ii) used a sample
not generalizable to the general or Aboriginal populations of the
respective country, or iii) reported a pooled estimate of alcohol use
during pregnancy by combining several studies.
In cases where a study reported more than one prevalence es-
timate of alcohol use/binge drinking, preference was given to the
estimate obtained: i) after pregnancy recognition (rather than prior
to recognition), ii) during of the entire pregnancy (as opposed to
during just one trimester), iii) within 6 weeks postpartum, and/or
iv) using a validated tool for ascertainment of alcohol use.2.1.3. Data selection and extraction
Study selection began by screening titles and abstracts for in-
clusion. Then, full-text articles of all studies screened as potentially
relevant were considered. Two investigators conducted each study
selection step independently; any disagreements were reconciled
by team discussion. In cases where multiple studies used the same
dataset or cohort, the study with the larger sample size was
included.
All data were extracted by one investigator and then indepen-
dently cross-checked by a second investigator for accuracy against
the original studies. All discrepancies were reconciled by team
discussion.2.1.4. Meta-analysis
In order to estimate the pooled prevalence of alcohol use and
binge drinking during pregnancy, meta-analyses were performed
for each country assuming a random-effects model (DerSimonian
and Laird, 1986). Before performing the meta-analyses, preva-
lence estimates were transformed using a double arcsine trans-
formation so that the data followed a normal distribution (Freeman
and Tukey, 1950). Heterogeneity between estimates was assessed
using the Cochrane Q test (Cochran, 1954) and the I2 statistic
(Higgins and Thompson, 2002). Publication bias was tested by: i)
visually inspecting the funnel plot (standard error plotted against
the point estimate) for a skewed distribution, ii) using a ranked
correlation test (Begg and Mazumdar, 1994), and iii) employing a
weighted regression test (Egger et al., 1997). However, it was
decided that if publication bias were present it would not be
adjusted for, since the authors of this paper believe that the prev-
alence estimates of interest would likely be published even if
substantially different from previously reported estimates. The
results of the meta-analyses were displayed using Forest plots.
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2.2.1. Comprehensive systematic literature search strategy
A comprehensive systematic literature search was performed to
identify all studies that have reported the prevalence of FAS and/or
FASD among the general population and/or Aboriginal population
in Canada or the United States. The search was conducted in mul-
tiple electronic bibliographic databases, which included (in alpha-
betical order): CINAHL, Embase, ERIC, Medline, PsycINFO, Scopus,
and Web of Science (including Science Citation Index, Social Sci-
ences Citation Index, Arts and Humanities Citation Index). The
search was conducted using the following key words: 1) epi-
demiolog*, frequenc*, incidence*, morbidit*, occurren*, preva-
lence*, probability, rate*, OR statistic*; AND 2) alcohol*
embryopath*, alcohol* related* neurodevelopmental* disorder*,
alcohol* related* birth defect*, arnd, arbd, fetal* alcohol* effect*,
fae, fas, fasd, fetal alcohol syndrome*, fetal alcohol spectrum dis-
order*, fetal* alcohol* effect, foetal* alcohol syndrome*, foetal*
alcohol spectrum disorder*, pfas, partial fetal alcohol syndrome,
partial foetal alcohol syndrome, prenatal* alcohol expos*, OR pre-
natal* alcohol expos*; AND 3) cohort stud*, cross* sectional stud*,
prospective cohort stud*, OR retrospective cohort stud*; AND 4)
Canada, North America*, United States*, OR USA. The search was
not limited by language of publication, and was performed to
identify all studies published from January 1973 (when FAS was
ﬁrst described; Jones and Smith, 1973) up to the end of June 2015.
The search was limited to human studies in all databases that allow
for this restriction to be speciﬁed. Manual reviews of the content
pages of the major epidemiological journals were conducted, as
well as citations in any of the relevant articles.
2.2.2. Inclusion and exclusion criteria
Articles were retained if they met the following inclusion
criteria: i) consisted of original, quantitative research published in a
peer-reviewed journal or scholarly report; and ii) reported the
prevalence of FASD (or any of the diagnoses within the spectrum)
with a) a measure of uncertainty (conﬁdence interval or standard
error) or b) either the sample size or number of cases. Articles were
excluded if they: i) used a sample not generalizable to the general
or Aboriginal populations of the respective country, ii) reported a
pooled estimate by combining several studies, or iii) were pub-
lished in iteration.
2.2.3. Data selection and extraction
Please see the details on study selection and data extraction
provided above.
2.2.4. Meta-analysis
Articles identiﬁed in the comprehensive systematic literature
search were included in the meta-analyses if they met the
following inclusion criteria: i) used active case ascertainment or
clinic-based methods, and ii) speciﬁed the diagnostic guideline/
case deﬁnition used to ascertain cases. In order to estimate the
pooled prevalence of FAS and FASD, meta-analyses were performed
for each country assuming a random-effects model (DerSimonian
and Laird, 1986). For more details on the meta-analysis method-
ology, please see above.
2.2.5. Sensitivity analysis
A sensitivity analysis was conducted in order to estimate the
pooled prevalence of FAS and FASD using less restrictive inclusion
criteria. That is to say, studies that utilized passive surveillance
methods and/or did not specify the diagnostic guideline/case
deﬁnition used were also included.3. Results
3.1. Prevalence of Alcohol Use and Binge Drinking During Pregnancy
Among the General and Aboriginal Populations in Canada and the
United States
Initially, the search strategy for the prevalence of alcohol use
and binge drinking during pregnancy yielded a total of 5142
studies; of which, 125 studies contained relevant data and were
retained for data extraction (Fig.1). In total,115 studies reported the
prevalence of alcohol use during pregnancy among the general
population in Canada (n ¼ 14) and the United States (n ¼ 103); one
study reported the prevalence among a sample drawn from both
countries. Of these 115 studies, 20 reported the prevalence binge
drinking during pregnancy in Canada (n ¼ 1) and the United States
(n ¼ 19). Ten studies in total reported the prevalence of alcohol use
during pregnancy among the Aboriginal populations in Canada
(n ¼ 6) and the United States (n ¼ 4). Of these ten studies, four
reported the prevalence of binge drinking during pregnancy in
Canada (n ¼ 2) and the United States (n ¼ 2).
3.1.1. Pooled prevalence of alcohol use and binge drinking during
pregnancy among the general population
The pooled prevalence of alcohol use during pregnancy among
the general population was estimated to be 10.0% (95% conﬁdence
interval [CI]: 5.2%e16.2%) in Canada and 14.8% (95% CI: 12.0%e
18.0%) in United States. The pooled prevalence of binge drinking
during pregnancy among the general population was estimated to
be 3.3% (95% CI: 2.6%e4.2%; based on only one study) in Canada and
3.1% (95% CI: 1.7%e4.9%) in United States. See Table 1 for the study
characteristics and prevalence of alcohol use and binge drinking
during pregnancy among the general population reported in the
individual studies. For the pooled prevalence of alcohol use and
binge drinking during pregnancy among the general population
and the results of the heterogeneity and publication bias tests see
Table 2. The forest plots and funnel plots are presented in the
Appendix.
3.1.2. Pooled prevalence of alcohol use and binge drinking during
pregnancy among the Aboriginal population
The pooled prevalence of alcohol use during pregnancy among
the Aboriginal population was estimated to be 36.5% (95% CI:
24.7%e49.1%) in Canada and 42.9% (95% CI: 27.1%e59.4%) in United
States. The pooled prevalence of binge drinking during pregnancy
among the Aboriginal population was estimated to be 22.1% (95%
CI: 0.0%e52.9%) in Canada and 14.6% (95% CI: 6.6%e24.8%) in United
States. See Table 3 for the study characteristics and prevalence of
alcohol use and binge drinking during pregnancy among the
Aboriginal population reported in the individual studies. For the
pooled prevalence of alcohol use and binge drinking during preg-
nancy among the Aboriginal population and the results of the
heterogeneity and publication bias tests see Table 2. The forest plots
and funnel plots are presented in the Appendix.
3.2. Prevalence of FAS and FASD Among the General and Aboriginal
Populations in Canada and the United States
The search strategy for the prevalence of FAS/FASD yielded a
total of 3481 studies initially; yet, only 36 studies contained rele-
vant data and were retained for data extraction (Fig. 2). Twenty-
seven studies contained data on the prevalence of FAS/FASD
among the general population in Canada (n ¼ 2) and the United
States (n ¼ 25), and 13 studies reported on the prevalence of FAS/
FASD among the Aboriginal population in Canada (n ¼ 5) and the
United States (n ¼ 8).
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Fig. 1. Schematic diagram depicting the search strategy employed for the prevalence of alcohol use (any amount) and binge drinking during pregnancy among the general and
Aboriginal populations in Canada and the United States.
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population
The pooled prevalence of FAS and FASD among the Canadian
general population was estimated to be 1.1 per 1000 (95% CI:
0.0e3.5 per 1000) and 5.3 per 1000 (95% CI: 4.5e6.1 per 1000;
based on only one study), respectively. In the United States, the
pooled prevalence of FAS and FASD among the general population
was estimated to be 2.3 per 1000 (95% CI: 0.8e4.3 per 1000) and
15.2 per 1000 (95% CI: 7.5e25.3 per 1000), respectively. See Table 4
for the study characteristics and prevalence of FAS and FASD among
the general population reported in the individual studies. For the
pooled prevalence of FAS/FASD among the general population and
the results of the heterogeneity and publication bias tests see
Table 5. The forest plots and funnel plots are presented in the
Appendix.
3.2.2. Pooled prevalence of FAS and FASD among the Aboriginal
population
The pooled prevalence of FAS and FASD among the Aboriginal
population was estimated to be 41.6 per 1000 (95% CI: 0.0e133.4
per 1000) and 86.8 per 1000 (95% CI: 0.0e198.7 per 1000),
respectively, in Canada. In the United States, the pooled prevalence
of FAS and FASD among the Aboriginal populationwas estimated to
be 3.8 per 1000 (95% CI: 0.0e8.0 per 1000) and 9.5 per 1000 (95%
CI: 0.0e27.6 per 1000), respectively. See Table 6 for the study
characteristics and prevalence of FAS and FASD among the
Aboriginal population reported in the individual studies. For the
pooled prevalence of FAS/FASD among the Aboriginal population
and the results of the heterogeneity and publication bias tests see
Table 5. The forest plots and funnel plots are presented in the
Appendix.
3.2.3. Sensitivity analysis
The pooled prevalence of FAS among the general populationwasestimated to be 1.1 per 1000 (95% CI: 0.0e3.5 per 1000) in Canada
and 0.9 per 1000 (95% CI: 0.5e1.5 per 1000) in the United States.
The pooled prevalence of FASD among the general population in
Canada and the United States was estimated to be 5.3 per 1000 (95%
CI: 4.5e6.1 per 1000) and 9.8 per 1000 (95% CI: 3.2e19.5 per 1000),
respectively. The pooled prevalence of FAS among the Aboriginal
population was estimated to be 41.6 per 1000 (95% CI: 0.0e133.4
per 1000) in Canada and 2.4 per 1000 (95% CI: 1.4e3.7 per 1000) in
the United States. The pooled prevalence of FASD among the
Aboriginal population in Canada and the United States was esti-
mated to be 54.0 per 1000 (95% CI: 0.0e154.1 per 1000) and 9.5 per
1000 (95% CI: 0.0e27.6 per 1000), respectively. See Table 5 for the
results of the sensitivity analysis; the respective forest plots and
funnel plots are presented in the Appendix.4. Conclusions
Despite public health efforts to reduce alcohol consumption
during pregnancy in North America, the results of the current study
revealed that about 10% and 15% of women in the general popu-
lation consume alcohol during pregnancy in Canada and the United
States, respectively, and that about 3% of women engage in binge
drinking during pregnancy in both countries. However, it was
estimated that a much higher proportion (approximately 40%) of
women in the Aboriginal populations in North America consume
alcohol during pregnancy. Even more alarmingly, approximately
22% and 15% of Aboriginal women in Canada and the United States,
respectively, binge drink during pregnancy.
Although the prevalence of alcohol consumption during preg-
nancy in the general population of North America is signiﬁcant, it is
still lower than in other parts of the world. For instance, the pooled
prevalence of alcohol consumption during pregnancy in some
countries of Eastern Europe (e.g., 25.0% in Lithuania, 34.0% in
Ukraine, and 36.5% in Russia) and Western Europe (e.g., 27.0% in
Table 1
Study characteristics and the prevalence of alcohol use (any amount) and binge drinking during pregnancy among the general population in Canada and the United States
reported in the identiﬁed studies.
Reference Country (State/Province/
Territory)
Study year(s) Timing of data
collection
Sample
size
Setting Instrument used
to obtain alcohol
use data
Prevalence of
alcohol use
during pregnancy
(n [%])
Prevalence
of binge drinking
during pregnancy
(n [%])
Armstrong
et al., 1992
Canada (Quebec) 1982e84 Retrospective 47,146 Hospital-based Questionnaire 13,982 (29.7%) n/a
Burstyn et al.,
2010
Canada (Alberta) 2001e05 Retrospective 191,686 Hospital-based Medical
charts/records
3768 (2.0%) n/a
Caldeira and
Woodin,
2012
Canada (British Columbia) 2012 During pregnancy 98 Population-
based
AUDIT 11 (11.2%) n/a
Chalmers et al.,
2008
Canada 2006 Retrospective
(post-partum period)
6421 Population-
based
Questionnaire 674 (10.5%) n/a
Gareri et al.,
2008
Canada (Ontario) 2004e05 Retrospective
(post-partum
period)
1019 Hospital-based Questionnaire 5 (0.5%) n/a
Hicks et al.,
2014
Canada (Alberta) 2001e04 During pregnancy 1929 Hospital-based T-ACE 430 (22.3%) 64 (3.3%)
Holmes et al.,
2011 a
Canada & United States 1997e2010 During pregnancy (TT) 406 Population-
based
Questionnaire 122 (30.0%) n/a
Lange et al.,
2016
Canada 2003e10 Retrospective (5 years
postpartum)
18,612 Population-
based
Questionnaire 1791 (9.6%) n/a
Stewart and
Streiner,
1994
Canada (Ontario) 1992e93 During pregnancy
(ST & TT)
466 Hospital-based Questionnaire 68 (14.6%) n/a
Stoll et al., 2014 Canada (British Columbia) 2003e08 Retrospective 5031 Hospital-based Medical
charts/records
28 (0.6%) n/a
Tough et al.,
2001
Canada (Alberta) 1994e96 Retrospective 106,306 Population-
based
Medical
charts/records
7970 (7.5%) n/a
Weeks et al.,
2014
Canada 1994e97 Retrospective
(4e5 years
postpartum)
6337 Population-
based
Questionnaire 1065 (16.8%) n/a
Wenman et al.,
2002
Canada (Alberta) 1994e95 During pregnancy
(FT/ST)
1991 Hospital-based Questionnaire 348 (17.5%) n/a
Xiong et al.,
2000
Canada (Alberta) 1995e98 Retrospective
(time of delivery)
55,542 Population-
based
Medical
charts/records
1104 (2.0%) n/a
Adams et al.,
1995
United States 1987e90 Retrospective 1768 Hospital-based Medical
charts/records
175 (9.9%) n/a
Alderete et al.,
1995
United States (California) 1959e66 During pregnancy 1341 Hospital-based Questionnaire 518 (38.6%) 137 (10.2%)
Aliyu et al.,
2010
United States (Missouri) 1989e2005 Retrospective 1,221,677 Hospital-based Medical
charts/records
15,914 (1.3%) n/a
Altfeld et al.,
1997
United States (Illinois) 1990 Retrospective
(post-partum
period)
378 Hospital-based Questionnaire 89 (23.5%) n/a
Arfsten et al.,
2004
United States (Maryland) 2004 Retrospective
(1 year postpartum)
993 Population-
based
Questionnaire 242 (24.4%) n/a
Arria et al.,
2006
United States (California,
Iowa, Oklahoma, Hawaii)
2006 Retrospective
(post-partum period)
1632 Hospital-based Questionnaire 372 (22.8%) n/a
Astley, 2004 United States (Washington) 1993e95 Retrospective
(2e6 months
postpartum)
5740 Population-
based
Questionnaire 544 (9.5%) n/a
Bailey and
Daugherty,
2007
United States (North
Carolina)
2007 During pregnancy
(TT)
104 Hospital-based Questionnaire 2 (1.9%) n/a
Bailey et al.,
2008
United States (Washington) 1996e99 Retrospective 24 Population-
based
Timeline
follow-back
n/a 8 (33.3%)
Barrett et al.,
1993
United States (Illinois) 1990 During pregnancy 32 Population-
based
Questionnaire 6 (18.8%) n/a
Bauer et al.,
2002
United States 1993e95 Retrospective
(24 h after delivery)
9444 Hospital-based Questionnaire 3659 (38.7%) n/a
Bobo et al.,
2006
United States 1982e95 Retrospective 6676 Population-
based
Questionnaire 2130 (31.9%) n/a
Breslow et al.,
2007
United States 1993e94 During pregnancy
(TT) and retrospective
(3 months postpartum)
1548 Population-
based
Questionnaire 95 (6.1%) n/a
Brown et al.,
2010
United States 2001 Retrospective (6e22
months postpartum)
10,700 Population-
based
Questionnaire 300 (2.8%) n/a
Burd et al.,
2003
United States (North
Dakota)
2003 During pregnancy 1081 Hospital-based TWEAK 43 (4.0%) n/a
United States 2001e02 1515 139 (9.2%) n/a
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Table 1 (continued )
Reference Country (State/Province/
Territory)
Study year(s) Timing of data
collection
Sample
size
Setting Instrument used
to obtain alcohol
use data
Prevalence of
alcohol use
during pregnancy
(n [%])
Prevalence
of binge drinking
during pregnancy
(n [%])
Caetano et al.,
2006
During pregnancy and
retrospective
(1 year postpartum)
Population-
based
Alcohol Use
Disorder
and Associated
Disabilities
Interview
Schedule-IV
(AUDADIS-IV)
CDC, 1994 United States 1991 During pregnancy 1067 Population-
based
Questionnaire 147 (13.8%) 14 (1.3%)
CDC, 1995a United States 1988 During pregnancy 8396 Population-
based
Questionnaire 1738 (20.7%) n/a
CDC, 1997a United States 1995 During pregnancy 1313 Population-
based
Questionnaire 214 (16.3%) 38 (2.9%)
CDC, 2002a United States 1997 During pregnancy 1429 Population-
based
Questionnaire 163 (11.4%) 26 (1.8%)
CDC, 2002a United States 1999 During pregnancy 1888 Population-
based
Questionnaire 242 (12.8%) 51 (2.7%)
CDC, 2009 United States 2001e05 During pregnancy 13,820 Population-
based
Questionnaire 1548 (11.2%) 249 (1.8%)
CDC, 2012 United States 2006e10 During pregnancy 13,880 Population-
based
Questionnaire 1055 (7.6%) 194 (1.4%)
Chang et al.,
2011
United States
(Massachusetts)
2011 During pregnancy (ST) 30 Hospital-based T-ACE, CRAFFT,
medical
charts/record
8 (26.7%) n/a
Chasnoff et al.,
2005
United States (California,
Illinois, New Jersey)
2005 During pregnancy 4865 Hospital-based 4P's Plus Screen 512 (10.5%) n/a
Chung et al.,
2010
United States
(Pennsylvania)
2000e02 Retrospective (3
months postpartum)
1476 Hospital-based Questionnaire 99 (6.7%) n/a
Coleman et al.,
1989
United States 1989 During pregnancy
(TT)
153 Hospital-based Questionnaire 60 (39.2%) n/a
D'Angelo et al.,
2012
United States 2008 Retrospective (2e6
months postpartum)
35,446 Population-
based
T-ACE, CAGE,
MAST
2320 (6.5%) n/a
Declercq et al.,
1995
United States 1989e92 Retrospective 82,210 Population-
based
Medical
charts/records
2302 (2.8%) n/a
Derauf et al.,
2003
United States (Hawaii) 1999 Retrospective 436 Hospital-based Medical
charts/records
23 (5.3%) n/a
Detjen et al.,
2007
United States
(Massachusetts)
2000e04 During pregnancy
(FT & TT)
1130 Hospital-based Questionnaire 16 (1.4%) n/a
Dew et al., 2007 United States (Missouri) 1990e2002 Retrospective 82,856 Hospital-based Medical
charts/records
2140 (2.6%) n/a
Dlugosz et al.,
1996
United States (Connecticut) 1988e92 During pregnancy
(FT & ST)
2839 Hospital-based Questionnaire 1429 (50.3%) n/a
El-Khorazaty
et al., 2007
United States (Washington) 2001e03 During pregnancy
(ST)
1070 Hospital-based Questionnaire 229 (21.4%) n/a
El-Sayed and
Galea, 2012
United States (Michigan) 1989e2006 Retrospective 2,377,661 Population-
based
Questionnaire 38,710 (1.6%) n/a
Ethen et al.,
2009
United States (Arkansas,
California, Georgia, Iowa,
Massachusetts, New
Jersey, New York, Texas)
1997e2002 Retrospective
(2 years
postpartum)
4088 Population-
based
Questionnaire 1239 (30.3%) 338 (8.3%)
Erickson et al.,
1987
United States (Minnesota) 1980e82 Retrospective 923 Hospital-based Medical
charts/records
125 (13.5%) n/a
Faden and
Graubard,
1994
United States 1979e86 Retrospective 4409 Population-
based
Questionnaire 1506 (34.2%) n/a
Fenster et al.,
1997
United States (California) 1990e91 During pregnancy (FT) 5144 Hospital-based Questionnaire 397 (7.7%) n/a
Fortner et al.,
2011
United States
(Massachusetts)
2006e09 During pregnancy
(FT & ST)
916 Hospital-based Questionnaire 130 (14.2%) n/a
Flynn et al.,
2003
United States (Michigan) 1998e99 During pregnancy 1116 Hospital-based Abbreviated
TWEAK
169 (15.1%) 10 (0.9%)
Gardosi and
Fancis, 2000
United States 1988e95 During pregnancy 21,069 Hospital-based Medical
charts/records
6655 (31.6%) n/a
Gavin et al.,
2011
United States (Washington) 2011 n/a 136 Population-
based
Questionnaire 24 (17.6%) n/a
Getahun et al.,
2006
United States (Missouri) 1989e97 Retrospective 156,475 Hospital-based Medical
charts/records
3599 (2.3%) n/a
Goebert et al.,
2007
United States (Hawaii) 2007 n/a 84 Hospital-based TWEAK 11 (13.1%) n/a
Grant et al.,
2009a
United States (Washington) 1989e91 Retrospective 7178 Hospital-based Questionnaire 2125 (29.6%) 248 (3.5%)
(continued on next page)
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Table 1 (continued )
Reference Country (State/Province/
Territory)
Study year(s) Timing of data
collection
Sample
size
Setting Instrument used
to obtain alcohol
use data
Prevalence of
alcohol use
during pregnancy
(n [%])
Prevalence
of binge drinking
during pregnancy
(n [%])
Grant et al.,
2009b
United States (Washington) 1991e92 Retrospective 2230 Hospital-based Questionnaire 524 (23.5%) n/a
Grant et al.,
2009c
United States (Washington) 2002e04 Retrospective 3124 Hospital-based Questionnaire 372 (11.9%) 44 (1.4%)
Grewal et al.,
2008
United States (California) 1999e2003 Retrospective 700 Hospital-based Questionnaire 39 (5.6%) 9 (1.3%)
Havens et al.,
2009
United States 2002e03 During pregnancy 1800 Population-
based
Questionnaire 180 (10.0%) n/a
Haynes et al.,
2003
United States (Montana,
North and South Dakota)
2003 During pregnancy 232 Hospital-based n/a 24 (10.3%) n/a
Hobbs et al.,
2010
United States (Arkansas) 1998e2006 Retrospective 363 Population-
based
Questionnaire 114 (31.4%) n/a
Hoffman and
Hatch, 2000
United States (New York,
Pennsylvania)
1987e89 During pregnancy 662 Population-
based
Questionnaire
& medical
charts/records
41 (6.2%) n/a
Hoyert, 1996 United States 1989e90 During pregnancy 3,850,653 Hospital-based Medical
charts/records
131,716 (3.4%) n/a
Huang and
Reid, 2006
United States 1998e2002 Retrospective
(post-partum period)
4854 Hospital-based Questionnaire 534 (11.0%) n/a
Hueston et al.,
2003
United States 1996 Retrospective 2,958,309 Hospital-based Medical
charts/records
38,899 (1.3%) n/a
Jagodzinski and
Fleming,
2007
United States (Wisconsin) 2002e05 Retrospective
(post-partum period)
8283 Hospital-based CAGE 447 (5.4%) n/a
Jesse and Reed,
2004
United States (Kentucky,
West Virginia, Tennessee,
Virginia)
2004 During pregnancy (ST) 120 Hospital-based Questionnaire 2 (1.7%) n/a
Johnson et al.,
1994
United States (Washington) 1994 During pregnancy 234 Hospital-based Questionnaire 8 (3.4%) n/a
Jones-Webb
et al., 1999
United States (Minnesota) 1993 Retrospective
(post-partum period)
683 Population-
based
Questionnaire 171 (25.0%) n/a
Kearney et al.,
2004
United States
(Massachusetts)
2004 Retrospective
(post-partum period)
1940 Hospital-based Questionnaire
& medical
charts/records
258 (13.3%) n/a
Kelly et al.,
2001
United States (California) 2001 During pregnancy 186 Hospital-based CAGE 31 (16.7%) n/a
Klein and
Zahnd, 1997
United States (California) 1997 During pregnancy 401 Population-
based
CAGE 193 (48.1%) 55 (13.7%)
Knopik et al.,
2005
United States (Missouri) 1995e98 Retrospective
(postpartum period)
1936 Population-
based
Modiﬁed SSAGA 533 (27.5%) 67 (3.5%)
Lagiou et al.,
2006
United States
(Massachusetts)
1994e95 During pregnancy
(end of ST)
270 Hospital-based Questionnaire 214 (79.3%) n/a
Li et al., 2012 United States (Alabama) 1997e2001 During pregnancy (ST) 3046 Hospital-based Questionnaire 156 (5.1%) 18 (0.6%)
Little et al.,
1990a
United States (Washington) 1982e84 During pregnancy (ST)
& retrospective
(1 month postpartum)
463 Hospital-based Questionnaire 186 (40.2%) 12 (2.6%)
Lundsberg
et al., 1997
United States (Connecticut) 1988e92 During pregnancy 2714 Hospital-based Questionnaire 1354 (49.9%) n/a
Martin et al.,
1997
United States
(North Carolina)
1987e91 Retrospective 4708 Population-
based
Medical
charts/records
212 (4.5%) n/a
McPheeters
et al., 2005
United States 1995e2001 During pregnancy
(ST & TT)
2534 Hospital-based Questionnaire 1017 (40.1%) n/a
Merewood
et al., 2009
United States
(Massachusetts)
2005e07 Retrospective (within
72 h after delivery)
252 Hospital-based Questionnaire 17 (6.7%) n/a
Meschke et al.,
2003
United States (Minnesota) 2000e03 During pregnancy
(ﬁrst prenatal visit)
1704 Hospital-based Questionnaire 334 (19.6%) n/a
Meschke et al.,
2008
United States (Minnesota) 2001e03 During pregnancy
(ﬁrst prenatal visit)
4272 Hospital-based Questionnaire 1137 (26.6%) n/a
Meschke et al.,
2013
United States (Minnesota,
Montana, North and
South Dakota)
2001e03 During pregnancy
(ﬁrst prenatal visit)
9004 Hospital-based Questionnaire 1983 (22.0%) n/a
Mills et al.,
1993
United States (Illinois,
Massachusetts,
New York, Pennsylvania,
Washington)
1980e85 During pregnancy
(throughout)
423 Hospital-based Questionnaire 367 (86.8%) n/a
Mohllajee et al.,
2007
United States 1996e99 Retrospective (2e6
months postpartum)
87,087 Population-
based
Questionnaire 5229 (6.0%) n/a
Nayak and
Kaskutas,
2004
United States 1999e2001 During pregnancy 72 Population-
based
Questionnaire 4 (5.6%) n/a
Nolan et al.,
2010
United States (Ohio) 2003e05 Retrospective 1548 Hospital-based Medical
charts/records
6 (0.4%) n/a
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Table 1 (continued )
Reference Country (State/Province/
Territory)
Study year(s) Timing of data
collection
Sample
size
Setting Instrument used
to obtain alcohol
use data
Prevalence of
alcohol use
during pregnancy
(n [%])
Prevalence
of binge drinking
during pregnancy
(n [%])
Pegues et al.,
1994
United States (Alabama) 1991 During pregnancy 3554 Hospital-based Medical
charts/records
175 (4.9%) n/a
Perham-Hester
and Gessner,
1997
United States (Alaska) 1991e94 Retrospective (2e8
months postpartum)
6973 Population-
based
Questionnaire 616 (8.8%) n/a
Piper and
Corbett,
2012
United States (Idaho,
Oregon, Washington)
2012 Retrospective (5e18
years postpartum)
357 Population-
based
Questionnaire 65 (18.2%) n/a
Pirie et al., 2000 United States (Minnesota,
Washington)
1993e95 During pregnancy (FT) 7489 Hospital-based Questionnaire 389 (5.2%) n/a
Poser et al.,
1986
United States 1985 Retrospective 67 Population-
based
Questionnaire 16 (23.9%) n/a
Raymond and
Mills, 1993
United States (California) 1974e77 During pregnancy
(ﬁrst prenatal visit)
30,583 Hospital-based Questionnaire 14,546 (47.6%) n/a
Reed et al.,
2005
United States (Colorado) 1998e99 Retrospective 118,904 Hospital-based Medical
charts/records
1486 (1.3%) n/a
Sastry and
Hussey, 2003
United States (Illinois) 1990 Retrospective 48,416 Hospital-based Medical
charts/records
1355 (2.8%) n/a
Savage et al.,
2002
United States (Ohio) 2002 During pregnancy 10 Hospital-based Timeline
follow-back
5 (50.0%) n/a
Serdula et al.,
1991
United States (Arizona,
California, Florida, Georgia,
Idaho, Illinois,
Indiana, Kentucky,
Minnesota,
Montana, New York,
North Carolina, North
Dakota, Ohio, Rhode
Island, South Carolina,
Tennessee, Utah, District
of Columbia, West Virginia,
Wisconsin)
1985e88 During pregnancy 1712 Population-
based
Questionnaire 429 (25.1%) 4 (2.8%)
Shiono et al.,
1995
United States (Louisiana,
New York, Oklahoma,
Texas, Washington)
1984e89 During pregnancy (ST) 7470 Hospital-based Questionnaire 2549 (34.1%) n/a
Shu et al., 1995 United States (New York,
Pennsylvania)
1987e89 During pregnancy 504 Hospital-based Questionnaire 170 (33.7%) n/a
Silveira et al.,
2010
United States (Maryland) 2005e08 During pregnancy 2104 Hospital-based Medical
charts/records
66 (3.1%) n/a
Silveira et al.,
2012
United States
(Massachusetts)
2006e11 During pregnancy 953 Hospital-based Questionnaire 24 (2.5%) n/a
Stitely et al.,
2010
United States
(West Virginia)
2009 Retrospective 1074 Hospital-based Medical
charts/records
13 (1.2%) n/a
Sung, 2012 United States 2004e08 During pregnancy 6499 Population-
based
Questionnaire 694 (10.7%) n/a
Vassilev et al.,
2001
United States (New Jersey) 1990e91 Retrospective 209,560 Population-
based
Medical
charts/records
6220 (3.0%) n/a
Veach et al.,
1995
United States (Las Vegas) 1995 During pregnancy (ST) 134 Hospital-based CAGE 29 (21.6%) n/a
Vinikoor et al.,
2010
United States (North
Carolina)
2000e05 During pregnancy
(FT & ST)
1457 Hospital-based Questionnaire n/a 7 (0.5%)
Wells et al.,
2006
United States (Colorado) 2000e02 Retrospective 4528 Population-
based
Questionnaire 485 (10.7%) n/a
Windham et al.,
1995
United States (California) 1986e87 Retrospective (8e9
months postpartum)
1233 Hospital-based Questionnaire 662 (53.7%) n/a
Windham et al.,
1997
United States (California) 1990e91 During pregnancy (FT) 5142 Hospital-based Questionnaire 387 (7.5%) n/a
Woods et al.,
2010
United States (Washington) 2004e08 During pregnancy
(ST & TT)
1440 Hospital-based T-ACE 212 (14.7%) n/a
Zender et al.,
2001
United States (Colorado) 1996e97 During pregnancy 71 Hospital-based Questionnaire 3 (4.2%) n/a
FT: First Trimester; n/a: Not available; ST: Second Trimester; TT: Third Trimester.
a Included in the meta-analysis for both Canada and the United States (Holmes et al., 2011).
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be notably higher (Popova et al., submitted). However, the pooled
prevalence of consuming alcohol during pregnancy among
Aboriginal women in North America is slightly higher (36% in
Canada and 43% in the United States) as compared to the pooled
prevalence among Aboriginal women in Australia (34%; based on
unpublished data of the authors of this paper).Further, the pooled prevalence in the general population in
Canada was estimated to be about 1 per 1000 for FAS and 5 per
1000 for FASD; however, in the Aboriginal population it was about
38 and 16 times higher, respectively. It must be acknowledged that
these pooled prevalence estimates are based on a limited number
of outdated studies with numerous acknowledged methodological
limitations such as being conducted in small communities and
Table 3
Study characteristics and the prevalence of alcohol use (any amount) and binge drinking during pregnancy among the Aboriginal population in Canada and the United States
reported in the identiﬁed studies.
Reference Country (State/
Province/
Territory)
Study
year(s)
Timing of data collection Sample
size
Setting Instrument used to
obtain alcohol use
data
Prevalence of alcohol use (any
amount) during pregnancy (n
[%])
Prevalence of binge
drinking during
pregnancy (n [%])
Fraser et al.,
2012
Canada
(Nunavut)
1995
e2000
Mid-pregnancy (ST) 215 Hospital-
based
Timeline follow-
back
130 (60.5%) 82 (38.1%)
Godel et al.,
1992
Canada
(Northwest
Territories)
1987
e1990
n/a 145 Hospital-
based
Questionnaire 50 (34.5%) 18 (12.4%)
Godel et al.,
2000
Canada
(Northwest
Territories)
2000 Retrospective (6e11 years
postpartum)
70 School-
based
Questionnaire 17 (24.3%) n/a
Kelly et al.,
2011
Canada
(Ontario)
2009
e10
Retrospective 458 Hospital-
based
Medical charts/
records
116 (25.3%) n/a
Williams
and
Gloster,
1999
Canada
(Manitoba)
1994
e95
Retrospective 242 Population-
based
Questionnaire 123 (50.8%) n/a
Williams
et al.,
1999
Canada
(Manitoba)
1994 Retrospective 745 Hospital-
based
Medical charts/
records
196 (26.3%) n/a
Bull et al.,
1999
United States 1994
e95
During pregnancy (ﬁrst
prenatal visit; FT), and
retrospectively
208 Hospital-
based
T-ACE and medical
charts/records
111 (53.4%) n/a
Khan et al.,
2013
United States
(Alaska)
2013 During pregnancy (TT) 125 Hospital-
based
Questionnaire 54 (43.2%) 25 (20.0%)
Kvigne et al.,
1998
United States 1998 During pregnancy (ﬁrst
prenatal visit; FT)
177 Hospital-
based
Questionnaire 99 (55.9%) 19 (10.7%)
Westphal,
2000
United States 1988 Retrospective (post-partum
period)
763 Population-
based
Questionnaire 169 (22.1%) n/a
FT: First Trimester; n/a: Not available; ST: Second Trimester; TT: Third Trimester.
Table 2
Pooled prevalence of alcohol use (any amount) and binge drinking during pregnancy among the general population and Aboriginal population in Canada and the United States,
based on the available literature, and the results of the heterogeneity and publication biasa tests.
Country Number of
studies
Estimate
(%)
Lower 95% CI
(%)
Upper 95% CI
(%)
Heterogeneity tests Publication bias tests
I2 test Q statistic df (Q
statistic)
p-value (Q
statistic)
p-value (rank
test)
p-value (regression
test)
Prevalence of alcohol use during pregnancy among the general population
Canada 14 10.0% 5.2% 16.2% 100.0% 34,725.2 13 0 0.667 0.442
United
States
103 14.8% 12.0% 18.0% 100.0% 198,478.0 102 0 <0.001 0.022
Prevalence of binge drinking during pregnancy among the general population
Canada 1 3.3% 2.6% 4.2% e e e e e e
United
States
19 3.1% 1.7% 4.9% 99.1% 861.5 18 <0.001 0.238 <0.001
Prevalence of alcohol use during pregnancy among the Aboriginal population
Canada 6 36.5% 24.7% 49.1% 96.3% 130.1 5 <0.001 0.469 0.944
United
States
4 42.9% 27.1% 59.4% 96.3% 124.8 3 <0.001 0.750 0.083
Prevalence of binge drinking during pregnancy among the Aboriginal population
Canada 2 22.1% 0.0% 52.9% 96.9% 31.7 1 <0.001 e e
United
States
2 14.6% 6.6% 24.8% 79.7% 4.9 1 0.027 e e
CI: Conﬁdence Interval; df: degrees of freedom.
Note. Please see Tables 1 and 3 for the references of the studies included in each meta-analysis.
a For those countries with more than one available study.
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of full FAS. These estimates are not only out of date, but also, as a
result of the limitations listed above, are not generalizable to the
Canadian population or applicable for decision-making purposes.
Moreover, the majority of the existing studies have used clinic- or
record-based systems without active recruitment of subjects;
therefore, such prevalence estimates are likely to be under-
estimated in any given population (May and Gossage, 2001).
With respect to the United States, the pooled prevalence of FAS
and FASD was estimated to be about 2 per 1000 and 15 per 1,000,respectively, among the general population, and 4 per 1000 and 10
per 1,000, respectively, among the Aboriginal population. However,
the pooled prevalence of FASD among the Aboriginal population
was estimated to be lower (based on only two studies) than the
pooled prevalence of FASD among the general population. This is
unlikely given that the pooled prevalence of alcohol consumption
during pregnancy among Aboriginal women is almost three times
higher as compared to the prevalence among the general popula-
tion in the United States.
As expected, the pooled prevalence estimates of FAS and FASD
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Fig. 2. Schematic diagram depicting the search strategy employed for the prevalence of FAS and FASD among the general and Aboriginal populations in Canada and the United
States.
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sensitivity analysis with less restrictive inclusion criteria were
lower than those obtained in the main analysis. This is due to the
inclusion of studies that utilized passive surveillance (a method
known to produce lower prevalence estimates; May and Gossage,
2001). Based on the results obtained, it is obvious that more
rigorous epidemiological studies, using active case ascertainment,
are needed in both countries in order to obtain reliable FASD
prevalence estimates. The current FAS and FASD prevalence esti-
mates in both countries should be used with caution due to the
limited number of existing studies and their methodological ﬂaws.
Strengths of the current study include the comprehensive
search strategies, strict inclusion and exclusion criteria, rigorous
identiﬁcation of dual publications, and the analytical strategy.
However, there are some limitations to acknowledge. Some studies
included in meta-analyses of the prevalence of alcohol use during
pregnancy utilized non-representative sampling strategy, and did
not use validated tools to ascertain alcohol use. Further, self-
reported use of alcohol during pregnancy is sensitive to bias (e.g.,
social desirability bias, recall bias, and/or fear that the child may be
taken away; Lange et al., 2014) and for to this reason, the estimated
pooled prevalence of alcohol consumption during pregnancy may
be underestimated in both the general and Aboriginal populations.
Further, in regard to the FAS and FASD prevalence estimates in the
Aboriginal population, the data from individual reserves/commu-
nities might not be generalizable to the Aboriginal population as a
whole.
Moreover, the majority of studies included in this analysis
acknowledged that the reported FAS/FASD prevalence was most
likely underestimated. The main reason is that, unfortunately,
many individuals with FASD are unrecognized and/or mis-
diagnosed (Elias, 2013; O'Connor et al., 2006). A recently conducted
study reported that within their sample 87% of youths with FASDhad never been previously diagnosed or had been misdiagnosed
(Chasnoff et al., 2015). There are several barriers to the early
recognition and accurate diagnosis of individuals with FASD. Firstly,
despite the fact that most pediatricians in North America are aware
of FASD and its diagnostic features (Clarke et al., 2005; Gahagan
et al., 2006), a survey by the American Academy of Pediatrics
revealed that pediatricians are not adequately trained for actual
clinical diagnosis, referral, and management of patients with FASD
(Gahagan et al., 2006; only half of the survey respondents felt
prepared to make a diagnosis, and only 34% felt prepared to
manage and coordinate the treatment of children with FASD). A
national survey of health care providers in Canada has also iden-
tiﬁed lack of training as a barrier to the diagnosis of FASD (see
Clarke et al., 2005). Secondly, a large number of comorbid condi-
tions have been found to co-occur in individuals with FASD, which
likely “mask” the FASD diagnosis (Popova et al., 2016b). For
instance, studies have reported that from 40% to 75% of children
with FASD were incorrectly diagnosed, and that ADHD was the
most common referral diagnosis for children who were ultimately
diagnosed with FASD (Fryer et al., 2007; Rasmussen et al., 2010).
Most importantly, FASD has to be widely recognized as a pre-
ventable disorder, and as such, there is an urgent need for pre-
vention programs aimed to change the behaviour of consuming
alcohol during pregnancy, as well as pre-pregnancy (as it greatly
affects the likelihood of prenatal drinking; Floyd et al., 1999; Tough
et al., 2006). However, it must be acknowledged that FASD pre-
vention involves much more than simply providing information
about the risks of alcohol use during pregnancy. As such, in Canada,
the Public Health Agency of Canada has developed the Four-Part
Model of Prevention; the ﬁrst level involves board awareness
building and health promotion efforts, the second level involves a
discussion of alcohol use and the related risks with all women of
child bearing age and their support networks, the third level
Table 4
Study characteristics and prevalence of FAS and FASD among the general population reported in the studies identiﬁed and included in the meta-analyses, in Canada and the
United States.
Reference Country (State/
Province/Territory)
Study
year(s)
Sample
size
Number
of cases
of FAS
Prevalence
of FAS
(per 1000)
Number
of cases
of FASD
Prevalence
of FASD
(per 1000)
Diagnostic guidelines/Case
deﬁnition
Sex
(%
male)
Age range
(years)
Method
Asante and
Nelms-
Matzke,
1985
Canada (Northwest
British Columbia &
Yukon)
1983e84 33,485 82 2.45 176 5.26 Guidelines established by
the Fetal Alcohol Study
Group of the RSA (Rosett,
1980)
63.0 0e16 ACA
Habbick et al.,
1996
Canada
(Saskatchewan)
1992e94 331,475 194 0.59 n/a n/a Guidelines established by
the Fetal Alcohol Study
Group of the RSA (Rosett,
1980) and the criteria by
Sokol and Clarren (1989)
0.5e28.3 Mixed
methods
(ACA & PS)
Barr and
Streissguth,
2001
United States
(Washington)
1974e75 1439 n/a n/a 36 25.02 Case deﬁnitions provided n/a 0e7 CB
Burd et al.,
1999
United States
(North Dakota)
n/a 1013 6 5.92 n/a n/a Criteria by Sokol and
Clarren (1989)
n/a 3e14 ACA
CDC, 1995b United States 1979e93 9,434,560 2032 0.22 n/a n/a n/a n/a n/a PS
CDC, 1997b United States
(Georgia)
1981e89 285,538 29 0.10 70 0.25 IOM criteria (Stratton et al.,
1996)
n/a 3e10 PS
CDC, 2002b United States
(Alaska, Arizona,
Colorado)
1995e97 348,463 145 0.42 n/a n/a IOM criteria (Stratton et al.,
1996)
n/a n/a PS
Clarren et al.,
2001
United States
(Washington)
n/a 3740 7 1.87 26 6.95 4-digit diagnostic code
(Astley and Clarren, 1999)
n/a 6e7 ACA
Druschel and
Fox, 2007
United States (New
York)
1995e99 106,336 63 0.59 n/a n/a IOM criteria (Stratton et al.,
1996)
n/a 0e4 PS
Egeland et al.,
1998
United States
(Alaska)
1977e92 176,765 137 0.78 n/a n/a Case deﬁnition provided n/a 0e16 PS
Fox et al., 2015 United States
(Arizona, Colorado,
New York)
2010 472,457 161 0.34 n/a n/a Case deﬁnition based on
IOM criteria (Stratton et al.,
1996)
51.0 7e9 PS
Fox and
Druschel,
2003
United States (New
York)
1995e98 111,197 36 0.32 n/a n/a IOM criteria (Stratton et al.,
1996)
n/a 0e2 PS
Hansen et al.,
2014
United States
(Georgia)
2006e12 143,393 276 1.92 n/a n/a Case deﬁnition based on
IOM criteria (Stratton et al.,
1996)
n/a 0e12 PS
Hingson et al.,
1982
United States
(Boston)
1977e79 1690 1 0.59 37 21.89 Guidelines established by
the Fetal Alcohol Study
Group of the RSA (Rosett,
1980)
n/a 0 (live
births)
CB
Little, 1977 United States
(Washington)
n/a 801 0 0.0 n/a n/a n/a n/a 0-1
(newborns)
CB
Little et al.,
1990b
United States
(Texas)
1977e80 5602 6 1.07 17 3.03 n/a n/a n/a PS
May et al., 2014 United States
(Midwestern)
2010e11 1433 12 8.37 48 33.50 Clariﬁcation of the IOM
criteria (Hoyme et al., 2005)
51.8 6e7 ACA
May et al., 2015 United States
(Northern Plains)
2007e09 2334 7 3.0 26 11.14 Clariﬁcation of the IOM
criteria (Hoyme et al., 2005)
54.5 6e7 ACA
Moberg et al.,
2014
United States
(Colorado,
Michigan,
Minnesota,
Missouri, North
Dakota, Oregon,
South Dakota, and
Wisconsin)
2001e06 1,322,831 422 0.32 n/a n/a Case deﬁnition provided n/a n/a Mixed
method
(ACA & PS)
NBDPN, 1997 United States
(Arizona, Arkansas,
Hawaii, Iowa,
Massachusetts,
Missouri,
Oklahoma)
1985e95 1,090,440 182 0.17 n/a n/a n/a n/a 0-1
(newborns)
PS
NBDPN, 2000 United States (21
States)
1989e95 10,683,535 2455 0.23 n/a n/a n/a n/a 0-1
(newborns)
PS
NBDPN, 2003 United States (24
States)
1996
e2000
7,711,455 1150 0.15 n/a n/a n/a n/a 0-1
(newborns)
PS
Ouellette et al.,
1977
United States
(Boston)
1974 322 1 3.11 n/a n/a n/a n/a 0-1
(newborns)
CB
Poitra et al.,
2003
United States 1992
e2000
1384 6 4.34 7 5.06 Criteria by Sokol and
Clarren (1989)
n/a 5e6 ACA
Sokol et al.,
1980
United States
(Ohio)
1973e79 12,127 5 0.41 n/a n/a Criteria by Clarren and
Smith (1978)
n/a 0 (live
births)
PS
1979e81 8331 25 3.00 n/a n/a n/a CB
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Table 4 (continued )
Reference Country (State/
Province/Territory)
Study
year(s)
Sample
size
Number
of cases
of FAS
Prevalence
of FAS
(per 1000)
Number
of cases
of FASD
Prevalence
of FASD
(per 1000)
Diagnostic guidelines/Case
deﬁnition
Sex
(%
male)
Age range
(years)
Method
Sokol et al.,
1986
United States
(Ohio)
Guidelines established by
the Fetal Alcohol Study
Group of the RSA (Rosett,
1980)
0 (live
birth)
Weiss et al.,
2004
United States
(Wisconsin)
1998e99 56,257 13 0.23 n/a n/a IOM criteria (Stratton et al.,
1996)
n/a 21me41m Mixed
method
(ACA & PS)
ACA: Active case ascertainment; CB: Clinic-based; FAS: Fetal Alcohol Syndrome; FASD: Fetal Alcohol Spectrum Disorder; IOM: Institute of Medicine; PS: Passive surveillance;
RSA: Research Society on Alcoholism.
Table 5
Pooled prevalence of FAS/FASD among the general population and Aboriginal population in Canada and the United States, based on the available literature, and the results of
the heterogeneity and publication biasa tests.
Country Number of studies (references) Estimate
(per 1000)
Lower 95% CI
(per 1000)
Upper 95% CI
(per 1000)
Heterogeneity tests Publication bias tests
I2 test Q statistic df (Q
statistic)
p-value
(Q statistic)
p-value
(rank test)
p-value
(regression test)
Prevalence of FAS among the general population
Canada 2 (Asante and Nelms-Matzke, 1985;
Habbick et al., 1996)
1.1 0.0 3.5 98.7% 78.7 1 <0.001 e e
United States 9 (Burd et al., 1999; Clarren et al., 2001;
Hingson et al., 1982; May et al., 2014, 2015;
Moberg et al., 2014; Poitra et al., 2003;
Sokol et al., 1986; Weiss et al., 2004)
2.3 0.8 4.3 97.9% 135.4 8 <0.001 0.119 <0.001
Prevalence of FASD among the general population
Canada 1 (Asante and Nelms-Matzke, 1985) 5.3 4.5 6.1 e e e e e e
United States 6 (Barr and Streissguth, 2001; Clarren et al.,
2001; Hingson et al., 1982; May et al., 2014,
2015; Poitra et al., 2003)
15.2 7.5 25.3 93.4% 71.6 5 <0.001 0.272 0.240
Prevalence of FAS among the Aboriginal population
Canada 3 (Kowlessar, 1997; Robinson et al., 1987;
Williams et al., 1999)
41.6 0.0 133.4 94.2% 39.0 2 <0.001 0.333 <0.001
United States 3 (Duimstra et al., 1993; May et al., 1983;
Quaid et al., 1993)
3.8 0.0 8.0 66.8% 5.8 2 0.056 0.333 0.021
Prevalence of FASD among the Aboriginal population
Canada 3 (Asante and Nelms-Matzke, 1985;
Kowlessar, 1997; Robinson et al., 1987)
86.8 0.0 198.7 95.2% 46.9 2 <0.001 0.333 <0.001
United States 2 (May et al., 1983; Quaid et al., 1993) 9.5 0.0 27.6 90.7% 10.8 1 0.001 e e
Sensitivity Analysis: Prevalence of FAS among the general population
Canada 2 (Asante and Nelms-Matzke, 1985;
Habbick et al., 1996)
1.1 0.0 3.5 98.7% 78.7 1 <0.001 e e
United States 24 (Burd et al., 1999; CDC, 1995b, 1997b,
2002b; Clarren et al., 2001; Druschel and
Fox, 2007; Egeland et al., 1998; Fox et al.,
2015; Fox and Druschel, 2003; Hansen et al.,
2014; Hingson et al., 1982; Little, 1977;
Little et al., 1990b; NBDPN, 1997, 2000,
2003; May et al., 2014, 2015; Moberg et al.,
2014; Ouellette et al., 1977; Poitra et al.,
2003; Sokol et al., 1980, 1986; Weiss et al.,
2004)
0.9 0.5 1.5 99.9% 1191.1 23 <0.001 0.902 <0.001
Sensitivity Analysis: Prevalence of FASD among the general population
Canada 1 (Asante and Nelms-Matzke, 1985) 5.3 4.5 6.1 e e e e e e
United States 8 (Barr and Streissguth, 2001; CDC, 1997b;
Clarren et al., 2001; Hingson et al., 1982;
Little et al., 1990b; May et al., 2014, 2015;
Poitra et al., 2003)
9.8 3.2 19.5 98.4% 579.6 7 <0.001 0.109 <0.001
Sensitivity Analysis: Prevalence of FAS among the Aboriginal population
Canada 3 (Kowlessar, 1997; Robinson et al., 1987;
Williams et al., 1999)
41.6 0.0 133.4 94.2% 39.0 2 <0.001 0.333 <0.001
United States 8 (CDC, 1995c; Chavez et al., 1988; Duimstra
et al., 1993; Egeland et al., 1998; Fox et al.,
2015; May et al., 1983; NBDPN, 2003; Quaid
et al., 1993)
2.4 1.4 3.7 94.7% 203.2 7 <0.001 0.905 0.016
Sensitivity Analysis: Prevalence of FASD among the Aboriginal population
Canada 4 (Asante and Nelms-Matzke, 1985;
Kowlessar, 1997; Robinson et al., 1987;
Werk et al., 2013)
54.0 0.0 154.1 99.6% 222.6 3 <0.001 0.750 <0.001
United States 2 (May et al., 1983; Quaid et al., 1993) 9.5 0.0 27.6 90.7% 10.8 1 0.001 e e
CI: Conﬁdence Interval; df: degrees of freedom; FAS: Fetal Alcohol Syndrome; FASD: Fetal Alcohol Spectrum Disorder.
a For those countries with more than one available study.
S. Popova et al. / European Journal of Medical Genetics 60 (2017) 32e48 43
Table 6
Study characteristics and prevalence of FAS and FASD among the Aboriginal population reported in the studies identiﬁed and included in themeta-analyses for Canada and the
United States.
Reference Country (State/Province/
Territory)
Study
year(s)
Sample
size
Number
of cases
of FAS
Prevalence
of FAS
(per 1000)
Number
of cases
of FASD
Prevalence
of FASD
(per 1000)
Diagnostic
guidelines/Case
deﬁnition
Sex
(%
male)
Age
range
(years)
Method
Asante and
Nelms-
Matzke,
1985
Canada (Northwest
British Columbia &
Yukon)
1983e84 5065 n/a n/a 166 32.77 Guidelines
established by the
Fetal Alcohol Study
Group of the RSA
(Rosett, 1980)
63.0 0e16 ACA
Kowlessar,
1997
Canada (Manitoba) 1981e90 178 11 61.80 19 101.12 IOM criteria (Stratton
et al., 1996)
n/a 5e15 ACA
Robinson et al.,
1987
Canada (British
Columbia)
1984e85 116 14 120.69 22 189.66 Guidelines
established by the
Fetal Alcohol Study
Group of the RSA
(Rosett, 1980)
49.6 3e18 ACA
Werk et al.,
2013
Canada 2006 11,868 n/a n/a 83 7.00 n/a n/a 0e5 PS (survey)
Williams et al.,
1999
Canada (Manitoba) 1994e96 696 5 7.18 n/a n/a IOM criteria (Stratton
et al., 1996)
n/a n/a Mixed methods
(ACA & PS)
Chavez et al.,
1988
United States 1981e86 19,412 58 2.99 n/a n/a n/a n/a 0-1
(newborns)
PS
CDC, 1995c United States (Iowa,
Nebraska, North Dakota,
South Dakota)
1981e92 22,222 60 2.70 n/a n/a Criteria by Sokol and
Clarren (1989)
n/a 0e31 PS
Duimstra et al.,
1993
United States (Northern
Plains)
1987e90 1022 4 3.91 n/a n/a Guidelines
established by the
Fetal Alcohol Study
Group of the RSA
(Rosett, 1980)
n/a 5me18m ACA
Egeland et al.,
1998
United States (Alaska) 1977e92 37,346 114 3.05 n/a n/a Case deﬁnition
provided
n/a 0e16 PS
Fox et al., 2015 United States (Arizona,
Colorado, New York)
2010 13,938 28 2.01 n/a n/a Case deﬁnition based
on IOM criteria
(Stratton et al., 1996)
n/a 7e9 PS
May et al., 1983 United States
(Southwestern United
States: New Mexico,
Southern Colorado,
Southern Utah, Northern
Arizona)
1980e82 22,963 55 2.40 85 3.70 Case deﬁnition
provided
55.6 0e14 ACA
NBDPN, 2003 United States (24 States) 1996
e2000
77,630 32 0.41 n/a n/a n/a n/a 0-1
(newborns)
PS
Quaid et al.,
1993
United States (Central
Oregon)
1991 429 4 9.32 8 18.65 Criteria by Sokol and
Clarren (1989)
n/a 0e3 ACA
ACA: Active case ascertainment; FAS: Fetal Alcohol Syndrome; FASD: Fetal Alcohol Spectrum Disorder; IOM: Institute of Medicine; PS: Passive surveillance; RSA: Research
Society on Alcoholism.
S. Popova et al. / European Journal of Medical Genetics 60 (2017) 32e4844involves specialized, holistic support of pregnant women with
alcohol and other health/social problems, and the fourth level in-
volves postpartum support for new mothers assisting them to
maintain/initiate changes in their health and social networks and to
support the development of their children (Poole, 2008). Similar
plans of action have been proposed in the United States (Barry et al.,
2009) and Australia (Elliott, 2015). Such strategies are in line with
the international charter on prevention of FASD, published in The
Lancet Global Health in 2014, calling on governments to take action
to raise awareness of FASD and the risks of alcohol use during
pregnancy (Jonsson et al., 2014). It is also in line with the WHO
global strategy to monitor and reduce the harmful use of alcohol,
endorsed by the 63rd World Health Assembly (WHO, 2010), which
highlights the importance of prevention and identiﬁcation of the
harmful use of alcohol among pregnant women and women of
childbearing age in all countries. Accordingly, the World Health
Organization (WHO) recently developed guidelines for the identi-
ﬁcation and management of substance use in pregnancy (WHO,
2014).
Finally, it is also very important to establish national surveil-
lance systems in order to monitor the prevalence of FASD. The FetalAlcohol Syndrome Surveillance Network II (FASSNetII, 2009e2014)
is an example of an FASD surveillance system that currently exists
in the United States, in which three states participate: Arizona,
Colorado, and New York (O'Leary et al., 2015). More like this need to
be established in Canada and the United States.
The harmful effects of alcohol on the fetus and FASD should be
well recognized by health care workers and other professionals,
and prevention, treatment and care interventions should be effec-
tively implemented at the policy and program levels in all countries
in order to achieve alcohol-free pregnancies in future.
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.ejmg.2016.09.010.
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